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ABSTRACT 
Objective: In continuation of the work on Benzoxazoles present work deals with the synthesis,characterization and evaluation of 2-Amino-N-
(substituted alkyl) benzoxazole-5- carboxamides for anti-inflammatory and antioxidant activities. 
Methods: Synthetic methodology of benzoxazoles from 4-carbomethoxynitrophenol.Evaluation of compounds for anti-inflammatory activity by 
carragenean induced rat paw odema method and antioxidant activity by DPPH method. 
Results: Among them compounds Vc(R=ethyl), Ve(R=propyl) and Vg (R=diisopropyl) V g (R=propyl) were found to be potent compounds. 
Compound Vf (R=isopropyl) showed comparatively more percentage of free radical scavenging activity with IC 50 of 4.65 when compared with the 
standard ascorbic acid. 
Conclusion: Vf is considered to be the dual anti-inflammatory and antioxidant agent.  
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INTRODUCTION 
Targets containing the Benzoxazole moiety [1-2] are considered to 
be important in view of their varied pharmacological properties 
such as anti-inflammatory[3], COX-2inhibitory[4] analgesic[5] 
antifungal, antibacterial[6],antitumor[7],antihistaminic, 
antiparasitic, herbicidal, antiallergic, antihelmintic, anticancer[8-
9],antitubercular, anticonvulsant[10], diarrhea-predominant 
irritable syndrome, hypoglycaemic,HIV-1 reverse transcriptase 
inhibitor insecticidal, elastase inhibitors,H2-antagonists,have a 
number of optical applications such as photoluminescents, 
whitening agents and dye laser. Marketed drugs containing the 
benzoxazole are ‘boxazomycin B47’ calcymicin, benzoxaprofen, 
Zoxazolamine, Chloroxazone either isolated from plants or accessed 
by total synthesis [11-12]. As a part of continuation of the work 
modifications has done on the previously synthesized molecules in 
order to reduce side effects and to explore benzoxazoles as anti-
inflammatory and antioxidant agents. 
In continuation of such investigations and in a search for less toxic 
and pharmacologically more potential benzoxazole derivatives we 
have taken up the synthesis of Benzoxazole carboxamide derivatives 
involving 5 steps as mentioned in the Figure (1) and their physical 
data (Table -2)and evaluation for anti-inflammatory,antioxidant 
activities of some new benzoxazole derivatives [13-15]. 
MATERIALS AND METHODS 
The synthetic methodology involves the nitration of carbomethoxy 
phenol and subsequent reduction with sodium dithionate and 
further cyclization with cyanogens bromide and reaction with 
substitiuted amines produces title compounds. 
synthesis of 4-carbomethoxy-2-nitrophenol (ii) 
To a solution of aluminium nitrate (0.1M) in acetic acid- acetic 
anhydride (1:1) mixture (160ml), was added an appropriate phenol 
(I, 0.1M) in small portions, while cooling and shaking occasionally. 
The reaction mixture was left at room temperature for 1.5 hours 
while shaking the contents intermittently to complete the nitration. 
The resulting brown solution was diluted to complete the nitration 
with ice-cold water and acidified with concentrated Nitric acid to get a 
bulky, yellow precipitate. It was filtered, washed with small quantity of 
methanol and purified by recrystallization from alcohol and yellow 
coloured crystalline solid was obtained. (yield 85%), m.p 73OC  
Synthesis of 4-carbomethoxy-2-aminophenol (iii) 
4-Carbomethoxy-2-nitrophenol (II, 0.05M) was dissolved in boiling 
alcohol (50%, 100ml) and sodium dithionite was added to this 
boiling alcohol solution until it became almost colourless. Then, the 
alcohol was reduced to one-third of its volume by refluxing and the 
residual liquid was triturated with crushed ice. The resulting 
colourless, shiny product was filtered, washed with cold water and 
dried in the air. Its purification was effected by recrystallization 
from benzene to get colourless, shiny scales (80%) m.p 143OC  
synthesis of methyl-2-aminobenzoxazole-5-carboxylate (iv) 
4-Carbomethoxy-2-aminophenol (III, 1.3 M) was dissolved in 1litre 
methyl alcohol and cooled the solution to 5OC in chopped ice.A cold 
suspension of cyanogen bromide (1.5 M) in 1litre of water was 
added over a period of 5min with rapid stirring. The reaction 
mixture was stirred for 45min at room temperature, solid sodium 
bicarbonate (1.3 M) was added in small portions over a period of 1.5 
hrs to bring the PH 6.5 -7.0. Stirring was continued for another 
1hour. The solid was separated by filtration, washed with cold water 
and on recrystallization from ethyl alcohol has resulted white solid, 
yield 70% and m.p is 238OC. 
synthesis of 2-amino-n-[substituted alkyl]-benzoxazole-5- 
carboxamides (v) 
A mixture of methyl-2-aminobenzoxazole-5-carboxylate (IV,0.01M) 
and alkylamine (0.01M) were taken in 50ml of methanol, heated 
under reflux on a water bath for 24-48hrs. The alcohol was reduced 
to half of its volume and cooled. The product separated was filtered 
and washed with small portions of cold alcohol first and then with 
cold water repeatedly and dried. The product was purified by 
recrystallization from suitable solvents. The compounds were 
characterized by spectral data [11-12]. 
Experiment methods 
Acute Toxicity [16] 
Healthy and adult male albino swiss mice weighing between 20-25g 
were used in the present investigation. Animals were fasted for 
24hours and divided into group of six each.The test compounds 
suspended in sodium carboxy methyl cellulose solution (0.1%)were 
administered intraperitoneally. The control groups of animals 
received only the vehicle (0.1% sodium carboxymethyl cellulose 
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solution). The animals were observed for 48 hours from the time of 
administration of test compound to record the mortality.The dose 
level to be used as the starting dose was selected from one of four 
fixed levels 5, 50, 300 and 2000 mg/kg body weight. The starting 
dose level should be that which was most likely to produce mortality 
in some of the dosed animals. The flow charts of drawn below 
describe the procedure that should be followed for each of starting 
doses. 
 




All the experiments were carried out using Male Sprawge Dawley 
rats (250-300g) obtained from animal house, University College of 
Pharmaceutical Sciences, Kakatiya University, Warangal, India. On 
arrival the animals were placed at random and allocated to 
treatment groups in polypropylene cages with paddy husk as 
bedding. Animals were housed at a temperature of 24 ± 2oC and 
relative humidity of 30 – 70 %. A 12:12 light: day cycle was followed. 
All animals were allowed to free access to water and fed with 
standard commercial rat feed (Hindustan Lever). All the 
experimental procedures and protocols used in this study were 
reviewed by the Institutional Animal Ethics Committee, Kakatiya 
University, Warangal, India.  
Vehicle 
Test compounds and Indomethacin were suspended in 0.1% w/v 
carboxymethylcellulose sodium (CMC) and were administered 
intraperitoneally to animals. Carrageenan was diluted separately in 
normal saline and injected.  
Method [17] 
Sprague Dawley rats weighed between 250-300gm and fasted for 
24hours before the test. The animals were divided into five groups 
with six animals in each group. The volume of the right hind paw 
was measured using plethysmometer. This constituted the initial 
reading. Compounds were tested in dose of 100mg/kg body weight. 
Indomethacin (5mg/kg) was used as standard. The compounds were 
administered as suspension in sodium CMC (0.1%W/V) 
intraperitoneally one hour before the injection of carrageenan. 
Control group of animals received a suspension of sodium CMC only. 
0.1ml of 1.0%W/V carrageenan suspension in normal saline was 
injected into the plantar region of the right hind paw. The 
inflammation produced after injection of the phlogistic agent was 
measured at two hours intervals for 8hrs.  
 
Statistical Analysis 
Dunnets t test. 
Antioxidant activity by DPPH method [18] 
A simple method that has been developed to determine the 
antioxidant activity of the drug utilizes the stable 2,2- diphenyl-1-
picrylhydrazyl(DPPH) radical. The odd electron in the DPPH free 
radical gives a strong absorption maximum at 517nm and is purple 
in colour. The colour turns from purple to yellow as the molar 
absorptivity of the DPPH radical at 517nm reduces from 9660 to 
1640 when the odd electron of DPPH radical becomes paired with 
hydrogen from a free radical scavenging antioxidant to form the 
reduced DPPH+H+. The resulting decolourisation is stoichiometric 
with respect to the number of electrons captured. Antioxidant 
compounds may be water soluble, lipid soluble, insoluble or bound 
to cell walls. Hence extraction efficiency is an important factor in 
quantification of antioxidant activity of foods. Ascorbic acid (as the 
reference standard) and the sample are reacted with DPPH solution 
in methanol/water for 30mins at 350C in a test tube and the 
absorbance changes are measured at 517nm.  
 
Preparation of standard solution 
Ascorbic acid was used as standard for antioxidant activity. The 
weight equivalent to concentrations of 20, 40, 60, 80 and 100 µg/ml 
was weighed and dissolved in methanol. 
Preparation of test solution 
Stock solutions of samples were prepared by dissolving 10 mg of 
test sample in 9.5 ml of methanol and 0.5ml of DMSO to give 
concentration of 1000µg/ml.From the above stock solutions the 
concentrations of 20, 40, 60, 80 and 100 µg/ml were prepared by 
dissolving equivalent quantity in methanol. 
Method 
The method of Liyana-Pathiana and Shahidi was used for the 
determination of scavenging activity of DPPH free radical. To 1 ml of 
0.135 mM DPPH prepared in methanol was added 1.0 ml of test 
compounds ranging from 20-100 µg/ml. The reaction mixture was 
vortexed thoroughly and left in dark at room temperature for 30 
min. The absorbance was measured spectrophotometrically at 517 
nm. The scavenging ability of the test compounds was calculated 
using the standard equation. The IC50 values were given in table. 
The amount of DPPH radical was calculated following this equation:  
% inhibition of DPPH = [A0- As]/A0 × 100 
Where A0 is the absorbance of control and As is the absorbance of 
sample.Standard drug is Ascorbic acid. 
RESULTS AND DISCUSSION 
Spectral data 
2-amino-n-methyl-benzoxazole-5- carboxamides (va) 
3405(NH 2), 1685 (C=O), 1621 (C=N), 1138 (C-O-C);1HMR spectrum 
(DMSO-d6) (δ ppm) at: 8.84(d, 1H, Ar-H), 8.3(d,1H,Ar-
H),8.84(d,1H,Ar-H), 7.61(s,1H,NH),6.99(s,1H,NH2) 2.85(s,3H, 
CH3);MASS: 191.19 
2-amino-n-diethyl-benzoxazole-5- carboxamides (vb) 
3355(NH 2), 1650 (C=O), 1613(C=N), 1125(C-O-C).1HNMR spectrum 
(DMSO-d6) (δ ppm) at: 8.84(d, 1H, Ar-H), 8.3(d,1H,Ar-H),8.03(d,1H,Ar-
H), 7.45(d,1H,NH), 6.99(s,2H,NH2),2.5(s,6H, (CH3)2), 1.8(S,4H, 
(CH2)2);MASS: 233 
Parlapalli et al. 
Int J Pharm Pharm Sci, Vol 6, Issue 4, 311-314 
 
313 
2-amino-n-ethyl-benzoxazole-5- carboxamides (vc) 
3405(NH 2), 1685 (C=O), 1621 (C=N), 1138 (C-O-C).1HNMR 
spectrum (DMSO-d6) (δ ppm) at: 8.75(d, 1H, Ar-H), 8.14(s,1H,Ar-H), 
8.02(s,1H,NH),8.00(d,1H,Ar-H),,3.28(s,2H, CH2),1.8(s,3H,CH3);MASS: 
205 
2-amino-n-dimethyl-benzoxazole-5- carboxamides (vd) 
3405(NH 2), 1685 (C=O), 1621 (C=N), 1138 (C-O-C).1HNMR 
spectrum (DMSO-d6) (δ ppm) at: 8.75(d, 1H, Ar-H), 8.14(s,1H,Ar-H), 
8.02(s,1H,NH),8.00(d,1H,Ar-H),,7.00 (s,2H,NH2), 2.93 (s,6H, (CH3)2), 
1.8(s,3H,CH3);MASS: 205 
2-amino-n-propyl-benzoxazole-5-carboxamides (ve) 
3405(NH 2), 1685 (C=O), 1621 (C=N), 1138 (C-O-C).1HNMR 
spectrum (DMSO-d6) (δ ppm) at: 8.44(s,1H,Ar-H),8.14(d, 1H, Ar-H), 
7.8(d,1H,Ar-H),7.6(s,1H,Ar-H),7.0 (s,2H,NH 2 ), 3.20(s,4H,(CH2)2,1.8 
(s,4H,(CH2)2) 1.3(s,6H, (CH3) 2 );Mass: m/z 219 
2-amino-n-isopropyl-benzoxazole-5-carboxamides (vf) 
3405(NH 2), 1685 (C=O), 1621 (C=N), 1138 (C-O-C).1HNMR spectrum 
(DMSO-d6) (δ ppm) at: 7.9(d, 1H, Ar-H), 7.8(d,1H,Ar-H),7.6(s,1H,Ar-
H),7.1 (s,2H,NH2) ),3.94(s,1H,CH)2, 1.3(s,6H, (CH3) 2 ); Mass: m/z 219. 
2-amino-n-diisopropyl-benzoxazole-5- carboxamides (vg) 
3420(NH 2), 1674 (C=O), 1615 (C=N), 1124 (C-O-C).1HNMR 
spectrum (DMSO-d6) (δ ppm) at: 8.84 (s,1H,Ar-H), 8.14 (s, 1H, Ar-H), 
7.8(d,1H,Ar-H),7.6(s,1H,Ar-H),7.1 (s,2H,NH 2 ), 3.93(s,2H, (CH) 2 
).1.27(s,12H,(CH3)4) Mass: m/z 261 
Pharmacological evaluation 
The preliminary studies on antiinflammatory and antioxidant activity of 
the new benzoxazole derivatives have generated some interesting data.  
An attempt has been made to infer the ultimate out-come of the 
present studies basing on this data. 
Acute toxicity studies 
This study has been worked with the doses 5, 50, 300 and 
2000mg/kg (b.w). Mortality of the rats was observed with the dose 
of 2000 mg/kg (b.w). Again two more test doses that is 500 and 
1000 mg/kg (b.w) were administered. Mortality was observed with 
1000 mg/kg (b.w) and the test animals were safe at 500 mg/kg 
(b.w), intra-peritoneally, (b.w=body weight). 
Anti-inflammatory Activity 
All the synthesized new benzoxazole derivatives were evaluated for anti-
inflammatory activity at the concentration of 0.1 M and the results were 
compared with standard Diclofenac sodium (Table 1) for the period of 
eight hours with two hours interval. The investigation of 
antiinflammatory activity revealed that the tested compounds (Figure-2) 
Vc(R=ethyl), Ve(R=propyl) and Vf (R=diisopropyl) significantly reduced 
the carrageenan induced inflammation, with per cent inhibition 
34.60,35.30,33.33 respectively, there by showed a promising 
antiinflammatory activity, where as the compound Va (R=methyl),Vd 
(R=dimethyl) moderately reduced the inflammation with per cent 
inhibition27.89 and 31.90 respectively. Compound Vb (R=diethyl) Vf 
(R=isopropyl) with per cent inhibition 22.40 and 23.12 showed very 
poor anti-inflammatory activity towards carrageenan induced paw 
edema when compared to the standard drug Indomethacin with per cent 
inhibition 42.17 at first hour. 
Antioxidant activity 
All the synthesized new benzoxazole derivatives were evaluated for 
antioxidant activity(Figure-3) by DPPH method at the concentration 
of 20,40,60,80,100 µgm/ml concentration and the results were 
compared with standard Ascorbic acid (Table 3)at 20,40,60,80,100 
µg/ml concentration. 
 
Table 1: Anti-inflammatory activity of 2-Amino-N-(substituted alkyl) benzoxazole-5- carboxamides 
S. No.  R  1hr 2hr 3hr  4hr 
   Mean ±S.D Mean ±S.D Mean ±S.D Mean ±S.D 
1 Va Methyl 27.8±0.45 41.42±0.05*** 41.13±0.05*** 60.4±0.19 
2 Vb diethyl 22.4±0.085 28.58±0.14*** 55.0±0.05 38.3±0.28 
3 Vc ethyl 34.6±0.24 51.4±0.19 35.71±0.12 64.9±0.17 
4 Vd dimethyl 31.9±0.35 42.14±0.21*** 60.23±0.16 53.23±0.12 
5 Ve propyl 35.3±0.25 48.57±0.28 51.42±0.15 64.74±0.18 
6 Vf isopropyl 23.12±0.24 28.57±0.29 59.28±0.12 31.65±0.12 
7 Vg diisopropyl 33.33 ± 0.60 45.71±0.26 32.14±0.16 64.02±0.19 
8 Standard Diclofenac sodium 42.17±0.25 50±0.25 65±0.18 71.12±0.18 
Statistical significance: p<0.005 are significant., Number of animals used for the experiment: 06 
 
Table 2: Physical data of 2-Amino-N-(substituted alkyl) benzoxazole-5- carboxamides 
S. No.  R Mol formula Mol weight Melting point 0C  Yield 
1 Va C9H9N3O2 191.19 229-232 90 
2 Vb C12H15N3O2 233.27 204-206 86 
3 Vc C10H11N3O2 205.21 218-221 85 
4 Vd C10H11N3O2 205.21 223-225 70 
5 Ve C11H13N3O2 219.24 211-214 75 
6 Vf C11H13N3O2 219.24 241-244 81 
7 VIg C14H19N3O2 261.15 210-213 60 
 
Table 3: Antioxidant activity of 2-Amino-N-(substituted alkyl) benzoxazole-5- carboxamides 
S. No.  R  IC 50(µg/ml) Mean ±S.D 
1 Va Methyl 12.23±0.34 
2 Vb diethyl 16.43±0.23 
3 Vc ethyl 9.20±0.005 
4 Vd dimethyl 23.56±0.45 
5 Ve propyl 23.60±0.23 
6 Vf isopropyl 4.65±0.29 
7 Vg diisopropyl 11.12±0.27 
8 Standard Ascorbic acid 5.65±0.23 
Experiment carried out in triplicate 
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Among all the tested compounds Vg (R=diisopropyl) significantly 
showed potent antioxidant activity with IC50 4.65, where as the 
compound whereas rest of the compounds showed moderate 
antioxidant activity IC50 values in the range of 9.2 to 23.60. 
CONCLUSION 
Experimental approach for the synthesis was presented. The 
potential antiinflammatory and antioxidant activity validates the 
significance of the study. Among the synthesised compounds 2-
amino-N-isopropyl-benzoxazole-5-carboxamide (Vf) is considered 
to be the dual anti-inflammatory and antioxidant agent.  
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